Parker Michael Andrew 13D and 13G filings for Arch Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 12:39 pm Purchase |
2023-12-31 | 13G | Arch Therapeutics, Inc. ARTH |
Parker Michael Andrew | 213,529 4.500% |
107,340 (+101.08%) |
Filing |
| 2023-01-27 2:18 pm Unchanged |
2022-12-31 | 13G | Arch Therapeutics, Inc. ARTH |
Parker Michael Andrew | 106,189 8.497% |
0 (Unchanged) |
Filing |
| 2023-01-25 3:18 pm Purchase |
2022-12-31 | 13G | Arch Therapeutics, Inc. ARTH |
Parker Michael Andrew | 106,189 8.497% |
106,189 (New Position) |
Filing |